Risk profiles of subtypes of mild cognitive impairment: The sydney memory and ageing study

Journal of the American Geriatrics Society

Volumn 60, Issue 1, 2012, Pages 24-33

  Sachdev, Perminder S ^a,b   Lipnicki, Darren M ^a   Crawford, John ^a   Reppermund, Simone ^a   Kochan, Nicole A ^a   Trollor, Julian N ^a,c   Draper, Brian ^a,b,c   Slavin, Melissa J ^a   Kang, Kristan ^a   Lux, Ora ^a,c   Mather, Karen A ^a   Brodaty, Henry ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

amnestic; hypertension; mild cognitive impairment; risk factors; subtypes

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; HOMOCYSTEINE;

AGED; ALLELE; AMNESTIC MILD COGNITIVE IMPAIRMENT; ANTIHYPERTENSIVE THERAPY; ARTICLE; DEPRESSION; FEMALE; HEART DISEASE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MILD COGNITIVE IMPAIRMENT; MULTIPLE MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; NONAMNESTIC MILD COGNITIVE IMPAIRMENT; ODOR; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SINGLE MILD COGNITIVE IMPAIRMENT; SOCIAL BEHAVIOR; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HUMANS; INCIDENCE; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; NEW SOUTH WALES; POPULATION SURVEILLANCE; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84855823567     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03774.x     Document Type: Article

References (43)

1. Mitchell AJ, Shiri-Feshki M,. Temporal trends in the long term risk of progression of mild cognitive impairment: A pooled analysis. J Neurol Neurosurg Psychiatry 2008; 79: 1386-1391.
2. Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: Ten years later. Arch Neurol 2009; 66: 1447-1455.
3. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-246.
4. Hughes TF, Snitz BE, Ganguli M,. Should mild cognitive impairment be subtyped? Curr Opin Psychiatry 2011; 24: 237-242.
5. Busse A, Bischkopf J, Riedel-Heller SG, et al. Mild cognitive impairment: Prevalence and predictive validity according to current approaches. Acta Neurol Scand 2003; 108: 71-81.
6. Fischer P, Jungwirth S, Zehetmayer S, et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 2007; 68: 288-291.
7. Alexopoulos P, Grimmer T, Perneczky R, et al. Progression to dementia in clinical subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord 2006; 22: 27-34.
8. Ganguli M, Snitz BE, Saxton JA, et al. Outcomes of mild cognitive impairment by definition: A population study. Arch Neurol 2011; 68: 761-767.
9. Manly JJ, Tang MX, Schupf N, et al. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol 2008; 63: 494-506.
10. Nordlund A, Rolstad S, Klang O, et al. Two-year outcome of MCI subtypes and aetiologies in the Goteborg MCI study. J Neurol Neurosurg Psychiatry 2010; 81: 541-546.
11. Rasquin SM, Lodder J, Visser PJ, et al. Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: A 2-year follow-up study. Dement Geriatr Cogn Disord 2005; 19: 113-119.
12. Ritchie LJ, Tuokko H,. Patterns of cognitive decline, conversion rates, and predictive validity for 3 models of MCI. Am J Alzheimers Dis Other Demen 2010; 25: 592-603.
13. Diniz BS, Nunes PV, Yassuda MS, et al. Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study. Dement Geriatr Cogn Disord 2009; 27: 224-231.
14. Sachdev PS, Ganguli M, Petersen RC,. How can we best categorize cognitive impairment in nondemented older adults? Am J Geriatr Psychiatry 2010; 18: 657-661.
15. Artero S, Ancelin ML, Portet F, et al. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry 2008; 79: 979-984.
16. Folstein MF, Folstein SE, McHugh PR,. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
17. Anderson TM, Sachdev PS, Brodaty H, et al. Effects of sociodemographic and health variables on Mini-Mental State Exam scores in older Australians. Am J Geriatr Psychiatry 2007; 15: 467-476.
18. Australian Bureau of Statistics. Ageing in Australia: Census of Population and Housing 2001. Canberra, Australia: Australian Bureau of Statistics, 2003.
19. Sachdev PS, Brodaty H, Reppermund S, et al. The Sydney Memory and Ageing Study (MAS): Methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. Int Psychogeriatr 2010; 22: 1248-1264.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed., Text Revision. Washington, DC: American Psychiatric Association, 2000.
21. Hindmarch I, Lehfeld H, de Jongh P, et al. The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord 1998; 9: 20-26.
22. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale-A preliminary report. J Psychiatr Res 1983; 17: 37-49.
23. Waite LM, Broe GA, Grayson DA, et al. Preclinical syndromes predict dementia: The Sydney Older Persons Study. J Neurol Neurosurg Psychiatry 2001; 71: 296-302.
24. Doty RL, Marcus A, Lee WW,. Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope 1996; 106: 353-356.
25. Hixson JE, Vernier DT,. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-548.
26. Kim J, Basak JM, Holtzman DM,. The role of apolipoprotein E in Alzheimer's disease. Neuron 2009; 63: 287-303.
27. Nagga K, Rajani R, Mardh E, et al. Cobalamin, folate, methylmalonic acid, homocysteine, and gastritis markers in dementia. Dement Geriatr Cogn Disord 2003; 16: 269-275.
28. Qiu C, Winblad B, Marengoni A, et al. Heart failure and risk of dementia and Alzheimer disease: A population-based cohort study. Arch Intern Med 2006; 166: 1003-1008.
29. Mesholam RI, Moberg PJ, Mahr RN, et al. Olfaction in neurodegenerative disease: A meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 1998; 55: 84-90.
30. Wahl HW, Heyl V,. Connections between vision, hearing, and cognitive function in old age. Generations 2003; 27: 39-45.
31. He J, Farias S, Martinez O, et al. Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes. Arch Neurol 2009; 66: 1393-1399.
32. Reitz C, Tang MX, Manly J, et al. Hypertension and the risk of mild cognitive impairment. Arch Neurol 2007; 64: 1734-1740.
33. Roberts RO, Geda YE, Knopman DS, et al. Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: A population-based study. Alzheimer Dis Assoc Disord 2010; 24: 11-18.
34. Looi JC, Sachdev PS,. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 1999; 53: 670-678.
35. Skoog I, Gustafson D,. Update on hypertension and Alzheimer's disease. Neurol Res 2006; 28: 605-611.
36. Knopman DS, Roberts RO, Geda YE, et al. Association of prior stroke with cognitive function and cognitive impairment: A population-based study. Arch Neurol 2009; 66: 614-619.
37. van de Pol LA, Verhey F, Frisoni GB, et al. White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: The DESCRIPA study. J Neurol Neurosurg Psychiatry 2009; 80: 1069-1074.
38. Armstrong RA, Lantos PL, Cairns NJ,. Overlap between neurodegenerative disorders. Neuropathology 2005; 25: 111-124.
39. Brodaty H, Sachdev PS, Withall A, et al. Frequency and clinical, neuropsychological and neuroimaging correlates of apathy following stroke-The Sydney Stroke Study. Psychol Med 2005; 35: 1707-1716.
40. Sasaki M, Kodama C, Hidaka S, et al. Prevalence of four subtypes of mild cognitive impairment and APOE in a Japanese community. Int J Geriatr Psychiatry 2009; 24: 1119-1126.
41. Tsuno N, Homma A,. What is the association between depression and Alzheimer's disease? Expert Rev Neurother 2009; 9: 1667-1676.
42. Solfrizzi V, Panza F, Colacicco AM, et al. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004; 63: 1882-1891.
43. Valenzuela MJ, Breakspear M, Sachdev P,. Complex mental activity and the aging brain: Molecular, cellular and cortical network mechanisms. Brain Res Rev 2007; 56: 198-213.